Historical salary details - Mr. Gregg Anthony Lapointe, C.P.A.,M.B.A., Independent Director, Soligenix Inc
Mr. Gregg Anthony Lapointe, C.P.A.,M.B.A. is the Independent Director of Soligenix Inc. They also hold 2 other positions in Astria Therapeutics Inc and Rigel Pharmaceuticals.
Mr. Gregg Anthony Lapointe, C.P.A.,M.B.A.
Independent Director
$ 85.0 K
Gross Remuneration
-
Current Company
Soligenix Inc
| YEAR | COMPANY | POSITION | SALARY | INCREMENT |
|---|---|---|---|---|
| 2024 | Soligenix Inc | Independent Director | 85.0 K | 9.7 % |
| 2024 | Astria Therapeutics Inc | Independent Director | - | - |
| 2024 | Rigel Pharmaceuticals | Chairman of the Board | - | - |
| 2023 | Rigel Pharmaceuticals | - | 190.6 K | -4.6 % |
| 2023 | Astria Therapeutics Inc | Independent Director | 163.7 K | 134.3 % |
| 2023 | Soligenix Inc | Independent Director | 77.5 K | -11.4 % |
| 2022 | Rigel Pharmaceuticals | Chairman of the Board | 199.7 K | -16.9 % |
| 2022 | Soligenix Inc | Independent Director | 87.5 K | -2.8 % |
| 2022 | Astria Therapeutics Inc | Independent Director | 69.9 K | -61.8 % |
| 2021 | Rigel Pharmaceuticals | Independent Director | 240.4 K | 72.1 % |
| 2021 | Astria Therapeutics Inc | Independent Director | 182.9 K | 116.6 % |
| 2021 | Soligenix Inc | Independent Director | 90 K | 1.4 % |
| 2020 | Rigel Pharmaceuticals | Independent Director | 139.7 K | -6.1 % |
| 2020 | Soligenix Inc | Independent Director | 88.8 K | 11.1 % |
| 2020 | Astria Therapeutics Inc | Independent Director | 84.4 K | 3.5 % |
| 2020 | Plus Therapeutics Inc | Independent Director | - | - |
| 2019 | Rigel Pharmaceuticals | Independent Director | 148.8 K | -1.5 % |
| 2019 | Astria Therapeutics Inc | Independent Director | 81.6 K | - |
| 2019 | Soligenix Inc | Independent Director | 79.9 K | 3.1 % |
| 2019 | Plus Therapeutics Inc | Independent Director | 47.5 K | 5.6 % |
| 2018 | Rigel Pharmaceuticals | Independent Director | 151.0 K | -26.9 % |
| 2018 | Soligenix Inc | Independent Director | 77.5 K | 0.0 % |
| 2018 | Plus Therapeutics Inc | Independent Director | 45 K | -62.5 % |
| 2018 | Astria Therapeutics Inc | Independent Director | - | - |
| 2017 | Rigel Pharmaceuticals | Independent Director | 206.7 K | - |
| 2017 | Plus Therapeutics Inc | Director | 120 K | - |
| 2017 | Soligenix Inc | Independent Director | 77.5 K | 0.0 % |
| 2016 | Soligenix Inc | Independent Director | 77.5 K | 0.0 % |
| 2016 | Plus Therapeutics Inc | Independent Director | - | - |
| 2015 | Soligenix Inc | Independent Director | 77.5 K | 0.0 % |
| 2014 | Soligenix Inc | Independent Director | 77.5 K | 0.0 % |
| 2013 | Soligenix Inc | Independent Director | 77.5 K | 55.0 % |
| 2012 | Soligenix Inc | Independent Director | 50 K | -11.5 % |
| 2011 | Soligenix Inc | Independent Director | 56.5 K | 10.0 % |
| 2010 | Soligenix Inc | Director | 51.3 K | 10.6 % |
| 2009 | Soligenix Inc | Director | 46.4 K | - |
| 2008 | Soligenix Inc | Director | - | - |